Greg Losack

Greg Losack is an experienced epigenetic sales specialist at MDxHealth since October 2015, where the focus is on enhancing the early detection of clinically significant prostate cancer through non-invasive molecular diagnostics. Prior to this, Greg served as a senior professional sales specialist at Allergan (formerly Watson) from April 1998 to September 2015. Greg holds a Bachelor of Science degree in Criminal Justice from Texas State University.